Holen Sie sich die Stockscreener-App
1.35
6.90%
-0.10
Handel nachbörslich:
1.35
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt CAMP?
Forum
Prognose
Aktiensplit
Camp 4 Therapeutics Corp Aktie (CAMP) Neueste Nachrichten
Albany Ninja Lab Announces 2025 Summer Camp Programs - Yahoo Finance
CAMP4 Elects Directors and Ratifies Auditor - TipRanks
Calamp Corp : CalAmp to Present at Needham & Company 9th Annual Growth Stock Conference - marketscreener.com
CalAmp Corp. Announces CEO Changes, Effective January 22, 2024 - marketscreener.com
CalAmp Corp. Announces the Appointment of Paul Washicko as the New Senior Vice President of Product Management - marketscreener.com
Pre-market Movers: NIVF, TRAW, KKR, AGEN... - RTTNews
CAMP4 to Present at the 43rd Annual J.P. Morgan Healthcare Conference - The Globe and Mail
Wedbush sets CAMP4 stock at Outperform, $8 price target - Investing.com Australia
Wedbush sets CAMP4 stock at Outperform, $8 price target By Investing.com - Investing.com UK
Wedbush Initiates CAMP4 Therapeutics at Outperform With $8 Price Target - marketscreener.com
Parent's Night Out (6 months to 23 months) - Bucks County Herald newspaper
The Call EventsMount Saint Charles Middle School Field Hockey Clinic - woonsocketcall.com
ALT5 Sigma Corporation Announces Record Date for Alyea Therapeutics Corporation Transaction - The Joplin Globe
The Manufacturers Life Insurance Company Buys 3,095 Shares of Camping World Holdings, Inc. (NYSE:CWH) - Defense World
Therapeutic horseback riding facility hosts camp night for veterans, first responders - WSBT
CAMP4 Therapeutics Unveils Promising Data at ASGCT 2025 - TipRanks
CAMP4 Presents Translational Data from SYNGAP1-Related Disorders Program Showcasing Increased Protein in Non-Human Primates and Reviews Preclinical and Detailed Single Ascending Dose Safety Data from Urea Cycle Disorders Program at the 28th - The Manila Times
CAMP4 Therapeutics Reports Positive Results in SYNGAP1-Related Disorders and Urea Cycle Disorders at ASGCT Annual Meeting - Nasdaq
CAMP4 Clinical Data Shows 50% Protein Boost in Primate Brain Study | CAMP Stock News - Stock Titan
Upstream Bio Leads Life Sciences IPOs With Upsized Listing - MSN
CAMP4 Therapeutics: Promising Pipeline and Strong Financials Justify Buy Rating - TipRanks
CAMP4 Reports First Quarter 2025 Financial Results And Corporate Highlights - marketscreener.com
CAMP4 Therapeutics Provides Corporate Update and Reports First Quarter 2025 Financial Results - Nasdaq
CAMP4 Clinical Trials Hit Major Milestone: Q1 Earnings Show Strong Pipeline Progress in Rare Disease Treatment - Stock Titan
Prediction: Nvidia Just Received Its First Wall Street Sell Rating -- and More Will Follow After May 28 - The Globe and Mail
Northeast Ohio Parent Camp and Summer Programs Guide 2025 - Northeast Ohio Parent
Jesse Dee - UnionLeader.com
Sranan Gold Announces Positive Engagement with the Local Community, a Major Stakeholder at the Tapanahony Project in Suriname - Yahoo Finance
Wall Street Analysts Are Bullish on Top Healthcare Picks - The Globe and Mail
14-year-old dies by suicide at Weaverville mental health program run by owner of shuttered Trails Carolina - Asheville Watchdog
Angioedema Clinical Trial Pipeline Analysis Demonstrates 15+ Key Companies at the Horizon Expected to Transform the Treatment Paradigm, Assesses DelveInsight - GlobeNewswire Inc.
Pre-market Movers: KTTA, SXTC, GLMD, TCMD... - RTTNews
New Ulcerative Colitis Drug PALI-2108 Outperforms Standard Treatments in Crucial Disease Models - Stock Titan
Why ThredUp Shares Are Trading Higher By 20%; Here Are 20 Stocks Moving Premarket - Benzinga
Barrick Gold Trading Cheaper Than Industry: Time to Buy the Stock? - The Globe and Mail
Daily Times Chronicle EventsBoy Scout Troop 42 Pancake Breakfast - Homenewshere.com
CAMP4 to Present New Preclinical Data from its Urea Cycle Disorders and SYNGAP1-Related Disorders Programs at the 28th American Society of Gene and Cell Therapy Annual Meeting - The Manila Times
CAMP4 Therapeutics to Present Preclinical and Phase 1 Clinical Trial Data at 28th Annual Meeting of the American Society of Gene and Cell Therapy - Nasdaq
Revolutionary RNA Therapy Shows Promise: CAMP4 Unveils First Human Trial Data at Gene Therapy Conference - Stock Titan
Where's Plumpy'Nut? A lifesaving food for malnourished kids is caught up in U.S. cuts - NPR
Global School of Chess Announces 100 Full-Scholarship Seats for New Inclusivity & Awareness Camp - Yahoo Finance
Home | Department of Parks and Recreation - City and County of Honolulu (.gov)
Machine Learning-Assisted Spectroscopy Ensures Safety of Cell Therapy | Research & Technology | Apr 2025 - Photonics Spectra
Where Will Rigetti Computing Be in 10 Years? - The Globe and Mail
Programmable Therapeutics Restore Gene Expression - Mirage News
Restoring healthy gene expression with programmable therapeutics - MIT News
10 Barrel Brewing Co. and Scout Campers Unveil Camp Coldie: The Ultimate Adventure Beer - The Globe and Mail
Explorer Finds Major Gold Structure in Ontario Camp - streetwisereports.com
Top 3 Health Care Stocks Poised for Big Gains in Q2 - NewsBreak: Local News & Alerts
Top 3 Health Care Stocks That Could Lead To Your Biggest Gains In Q2 - Benzinga
Camp Sunrise returns for young kids dealing with grief; Teen Grief Retreat added - Central Oregon Daily
0.39%
0.42%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):